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The purpose of this study was to find the circulating microRNAs (miRNAs) co-related
with bone loss induced by bed rest, and testify whether the selected miRNAs could
reflect the bone mineral status of human after bed-rest. We analyzed plasma miRNA
levels of 16 subjects after 45 days of −6◦ head-down tilt bed rest, which is a reliable
model for the simulation of microgravity. We characterize the circulating miRNA profile in
individuals after bed rest and identify circulating miRNAs which can best reflect the level
of bone loss induced by bed rest. Expression profiling of circulating miRNA revealed
significant downregulation of 37 miRNAs and upregulation of 2 miRNAs, while only 11
of the downregulated miRNAs were further validated in a larger volunteer cohort using
qPCR. We found that 10 of these 11 miRNAs (miR-103, 130a, 1234, 1290, 151-5p,
151-3p, 199a-3p, 20a, 363, and 451a) had ROC curve that distinguished the status
after bed rest. Importantly, significant positive correlations were identified between bone
loss parameters and several miRNAs, eventually miR-1234 showed clinical significance
in detecting the bone loss of individuals after 45 days of bed rest.
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INTRODUCTION
Bone loss during long-term space flight is a key concern that poses significant risk to the health of
astronauts (Wang et al., 2012). Bone mineral density (BMD) declines is caused by the imbalance of
bone remodeling which is delicately regulated by both the number and activity of osteoblasts and
osteoclasts (Wang et al., 2013; Zhao et al., 2015). It is estimated that the rate of bone mineral loss
during spaceflight ranges from 0.5 to 1.5% per month, and its recovery requires three or four times
longer time period (Sibonga, 2013). Until now, BMD can be measured by the “gold standard”-
dual-energy X-ray absorptiometry (DXA). However, there is a challenge to obtain the small
changes compared with the precision of the measurement (Wheater et al., 2013). The noninvasive,
specific, and sensitive biomarker would be more feasible in this respect. Nevertheless, specific
markers in individuals during spaceflight or mimic microgravity are not well-established. Only
a few biomarkers concerning bone turnover exist including bone alkaline phosphatase (BALP),
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osteocalcin (OCN), and procollagen type I carboxy-terminal
propeptide (PICP; Wang et al., 2012; Wheater et al., 2013).
Head-down tilt (HDT) bed rest has proven to be a useful and
reliable model for most physiological effects for spaceflight.
This model has been used to test either resistive exercise or
other countermeasures for prevention of microgravity-or disuse-
induced bone loss (Wang et al., 2012; Yang et al., 2014).
Recent advances have identified miRNAs, which are
noncoding, ∼22-nucleotide-long RNAs that function as post-
transcriptional regulators of gene expression, as key regulators
of sophisticated gene expression to coordinate a broad spectrum
of biological processes (Ling et al., 2013a,b; Zhao et al., 2015).
Previous study by our group and others showed multiple
miRNAs have been identified to regulate the complex process
of bone remodeling (Wang et al., 2013; Chen et al., 2014). We
found that miR-214 directly targeted ATF4 to inhibit osteoblast
activity (Wang et al., 2013). Meantime, miR-214 promotes
osteoclastogenesis by targeting Pten in vitro and in vivo (Zhao
et al., 2015). miRNAs can be stable in plasma and serum and
have also attracted interest as putative circulating biomarkers of
diseases (Ward et al., 2014). Differential profiles of circulating
miRNA have been reported for osteoporotic fractures (Seeliger
et al., 2014), cardiovascular disease (McManus and Ambros,
2011; Roncarati et al., 2014), and cancer (Mitchell et al., 2008;
Ortega et al., 2015). However, signatures of circulating miRNAs
have not been characterized in individuals with bone loss
induced by bed rest or mimic microgravity.
In this study, we demonstrate the miRNA pattern in the
plasma of individuals after 45 days HDT bed rest. The levels
of miRNAs that existed significant difference between pre-
and post-bed rest were further assessed by quantitative real-
time polymerase chain reaction in an independent cohort. The
specificity and correlation of these miRNAs with bone loss
index were analyzed by ROC curve and co-relation analysis,
respectively. We identified miR-1234 correlated with BMD and
bone biochemical indices of individuals after 45 days bed rest.
MATERIALS AND METHODS
Participants
Sixteen male volunteers were invited to participate in the 45
days of −6◦ HDT bed rest experiment. The volunteers were
screened by a physical examination that included routinemedical
and laboratory tests to exclude chronic diseases-neurological
disorders, musculoskeletal system disorders, infectious diseases
and dyssomnia. Sixteen volunteers between 20 and 32 years
old (mean = 26.6, SD = 4.2). And all volunteers had received
greater than high school levels of education and were not taking
medications, drugs, smoking, or alcohol.
A detailed explanation of the study (research purpose,
whole experimental procedures and methods, conditions,
possible problems, and complications) was provided, and
written informed consent was subsequently obtained from each
participant. Participants received financial compensation at the
end of the study (Xu et al., 2013; Zhou et al., 2014). The
study protocol conformed to the ethical guidelines of the
1975 Declaration of Helsinki. The study was approved by the
Institutional Review Board of the China Astronaut Research and
Training Center.
Bone Mineral Density Measurements
Areal bone mineral density (aBMD, in grams per square
centimeter) of hip and lumbar spine (L2–L4) was measured
by DXA (Osteocore-1, MEDILINK Company, France). The
scans were performed according to standard clinical protocol
for each site. In each scan, regions of interest (ROI) were
defined by standard DXA protocol. Generally, BMD results
were acquired by built-in software of DXA. Precision of
DXA was calculated as the root mean squared coefficient of
variation (%CV) for repeated measurements (Supplementary
Table 2).
Biochemical Analysis
Biochemical analysis was performed according to manufacturer’s
protocol. Radioimmunoassay kits for measurement of serum
osteocalcin (OCN) levels were purchased from Atomic Energy
Institute of China (Beijing, China); bone alkaline phosphatase
(BALP), procollagen type I C propeptide (PICP), and beta-
carboxy-terminal cross-linking telopeptide of type I collagen
(β-CTX) were measured by ELISA.
Blood Collection
Peripheral blood samples (2ml) were collected into EDTA-
containing tubes. Then whole blood was centrifuged at 1200 g for
15min at room temperature within 30min after blood collection,
and the supernatant fluid was transferred into microcentrifuge
tubes, followed by a second centrifugation at 12,000 g for 10 min
at 4◦C to remove cellular debris. Plasma was then aliquoted and
stored at−80◦C until use.
MicroRNA Microarray Expression Profiling
Total RNAs isolated from plasma of four individuals before
and after 45 days of bed rest, respectively, were used for
microRNA microarray profiling. Total RNA was extracted from
400µl of plasma using the mirVanaTM RNA Isolation Kit
(Applied Biosystems, Foster City, CA, USA) according to the
manufacturer’s specifications, and eluted with 100µl of nuclease
free water.
Total RNA (100 ng) was quantified by the NanoDrop
ND-2000 (Thermo Scientific), and RNA integrity was assessed
using Agilent Bioanalyzer 2100 (Agilent Technologies). miRNA
microarray was performed and analyzed by the OEbiotech
Corporation in Shanghai, P.R. China. Sample labeling,
microarray hybridization and washing were performed as per
the manufacturer’s standard protocols. Briefly, total RNA were
dephosphorylated, denatured and then labeled with Cyanine-3-
CTP. After purification the labeled RNAs were hybridized onto
the microarray (Release 19.0, Agilent) containing probes for
2006 humanmicroRNAs. After washing, the arrays were scanned
with the Agilent Scanner G2505C (Agilent Technologies) and the
scanned images were analyzed using Agilent Feature Extraction
Software (Agilent Technologies).
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Circulating miRNA Extraction and
Detection by Quantitative-PCR
miRNA from 200 µl plasma was extracted using the
miRNeasy Serum/Plasma Kit, according to the manufacturer’s
recommendations (Qiagen, Germany). Briefly, samples were
supplemented (after addition of QIAzol) with 3.5 µl miRNeasy
Serum/Plasma Spike-In Control (1.6 × 108 copies/µl working
solution; Qiagen, Germany). The cel-miR-39 could be used for
normalization of the RNA preparation. The amount and purity of
RNA was estimated by quawell micro volume spectrophotometer
(Quawell, USA). Subsequently, miRNA was transcribed to cDNA
using the miScript II RT Kit (Qiagen, Germany). The cDNA
were used for detecting miRNA expression by Q-PCR using
the miScript SYBR Green PCR Kit with miScript Primer Assay
(Qiagen, Germany). The relative expression level of miRNA
was determined by the cycle number via Q-PCR, with levels
normalized to the average of cel-miR-39 using the 2−11CT
method.
Statistical Analyses
Data are expressed as mean ± standard deviation (SD)
or proportions where appropriate. Two-tail student’s t-
test was used to compare clinical characteristics between
groups. MicroRNA data are presented as fold change
relative to cel-miR-39 expression in each sample. Receiver
operating characteristics (ROC) curves and the area under
the ROC curve (AUC) were established to evaluate the
diagnostic value of plasma microRNAs whose levels differed
between before and post bed-rest. An AUC of 0.5 indicates
classifications assigned by chance. Based on ROC analysis,
the best statistical cutoff values of plasma microRNAs were
calculated, and the sensitivity and specificity for selected
cutoff points were then assessed. All statistical analysis
was performed using Graphpad Prism 5.01 for Windows
(Graphpad Software Inc., San Diego, CA, USA). Differences
were considered statistically significant at a value of P < 0.05
(two-tailed).
FIGURE 1 | Heat map of microRNA (miRNA) microarray expression data from plasma samples of individuals before and after 45 days of bed rest.
miRNA expression is hierarchically clustered on the y axis, and plasma samples from individuals before and bed rest are hierarchically clustered on the x-axis. The
legend on the right indicates the miRNA represented in the corresponding row. The relative miRNA expression is depicted according to the color scale shown on the
right. Red indicates downregulation; and yellow, upregulation. Numbers with A indicate the volunteer participated in the bed rest experiment, 45d indicated after 45
days of bed rest, −1d indicated 1 day before bed rest.
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RESULTS
Participants Characteristics
The microarray cohort of subjects included four individuals after
45 days of −6◦HDT bed rest. For independent validation, in
addition to the microarray cohort, we studied a second group
composed of 16 individuals in this 45 days of −6◦HDT bed rest
experiment.
Expression Profiles of microRNAs in the
Serum of Individuals after 45 Days Bed
Rest
To determine the differential miRNA levels in individuals after
45 days of –6◦HDT bed rest, we comparatively profiled serum
miRNA expression of four individuals before and after the HDT
bed rest, respectively (Baseline and BR-45). Paired sample T-
test was used to analysis the microarray data. The levels of
circulating miRNAs significantly differed after 45 days of bed
rest, as illustrated in the heat map shown in Figure 1. Of 2006
miRNAs detected on the microarray, 39 miRNAs were found to
be differentially expressed in individuals after 45 days bed rest (P
< 0.05). Levels of 37miRNAs were decreased and 2miRNAs were
increased in the plasma of individuals after 45 days bed rest. Fold
changes of levels of miRNAs in the array are shown in Table 1.
Quantitative Reverse Transcription
Polymerase Chain Reaction Validation of
the Profiling Data
To confirm miRNA profiling findings, we measured the levels of
the 39 dysregulated miRNAs on the basis of their fold changes
and P-values in microarray cohort via quantitative RT-PCR.
The relative level of significantly changed miRNA in individuals
is shown in Figure 2. Consistent with the profiling data, the
levels of 11 miRNAs were decreased in individuals after 45 days
bed rest (BR-45d) compared to baseline (Figure 2). Our results
demonstrated miR-20a, 103, 451, 130a, 1234, 1290, 148a, 151-
5p, 151-3p, 199a-3p, and 363 were significantly decreased and
there were no significantly upregulated miRNAs in the plasma
of individuals after 45 days bed rest.
Independent Validation of microRNA
Expression in Individuals after 45 Days of
Bed Rest and 10 Days of Recovery
Next, we focused our studies on the 11 miRNAs: miR-103, 130a,
1234, 1290, 148a, 151-5p, 151-3p, 199a-3p, 20a, 363, and 451a
which were verified by PCR on the basis of microarray results.
To independently validate the levels of these circulating miRNAs,
we studied a second set of plasma samples from 16 individuals
after 45 days bed rest and 10 days of recovery. Figure 3 showed
all these 11 miRNAs were significantly decreased in individuals
after 45 days bed rest compared with the baseline values. In
comparison with the BR-45d value, the levels of 3 miRNAs-
miR-103, 130a, and 1234 were significantly higher in plasma
of volunteers after 10 days of recovery. Interestingly, miR-151-
3p level was on a continuous decline. These results suggested
TABLE 1 | Properties of microRNAs differentially expressed in plasma of
individuals after 45 days of bed rest.
Downregulated
miRNAs
Fold
change
P-value Upregulated
miRNAs
Fold
change
P-value
hsa-miR-151-5p 0.19 0.000317 hsa-miR-1281 1.09 0.041138
hsa-let-7f 0.18 0.000467 hsa-miR-494 1.24 0.00532
hsa-miR-199a-3p 0.16 0.000519
hsa-miR-23b 0.19 0.000875
hsa-miR-30b 0.21 0.002515
hsa-miR-27a 0.15 0.002705
hsa-miR-766 0.25 0.004333
hsa-miR-1234 0.95 0.00605
hsa-miR-720 0.82 0.02101
hsa-miR-17 0.43 0.022664
hsa-miR-20a 0.43 0.023161
hsa-miR-16 0.78 0.024081
hsa-miR-21 0.78 0.026239
hsa-let-7a 0.44 0.030984
hsa-miR-103 0.3 0.031038
hsa-let-7i 0.75 0.033246
hsa-miR-151-3p 0.33 0.034416
hsa-miR-26b 0.34 0.035724
hsa-miR-642b 0.82 0.036784
hsa-miR-451 0.84 0.037804
hsa-miR-130a 0.33 0.038237
hsa-miR-130b 0.39 0.03925
hsa-let-7g 0.46 0.03935
hsa-miR-3202 0.85 0.039886
hsa-miR-363 0.37 0.040236
hsa-miR-148a 0.36 0.040796
hsa-miR-29b 0.38 0.040876
hsa-miR-101 0.34 0.042404
hsa-miR-1290 0.81 0.042588
hsa-miR-142-5p 0.34 0.043007
hsa-miR-223 0.77 0.045565
hsa-miR-150 0.53 0.046573
hsa-miR-24 0.42 0.04663
hsa-miR-4314 0.5 0.047719
hsa-miR-148b 0.36 0.047768
hsa-miR-4298 0.88 0.047836
hsa-miR-26a 0.48 0.049549
different circulating miRNA signatures might reflect the different
physiological changes induced by HDT bed rest.
ROC Analysis for Differential Expression of
Circulating miRNAs
To assess the potential detective value of the significantly
regulated miRNA in serum individuals after 45 days of bed
rest, a ROC curve analysis was performed. The associated area
under the curve (AUC) was used to confirm the diagnostic value
of each miRNA. As shown in Figure 4, the AUC of miR-130a
was the highest, reaching 0.9881 (95% confidence interval [CI]
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FIGURE 2 | Validation of microRNA (miRNA) microarray data by quantitative reverse-transcription polymerase chain reaction. The relative levels of
miRNAs were normalized to levels of the control (cel-miR-39). Baseline, pre-bed rest; BR-45d, post-45 days of bed rest. n = 4, the P-values were calculated by
2-tailed Student t-test. *P < 0.05, **P < 0.01.
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FIGURE 3 | Independent validation of microRNA expression in individuals after bed rest. Quantitative reverse transcription polymerase chain reaction for 11
signature miRNAs in an independent validation set of 16 subjects. The relative levels of miRNAs were normalized to levels of the control (cel-miR-39). Baseline, pre-bed
rest; BR-45d, post-45 days of bed rest; R-10d, recovery for 10 days. P values were calculated by 2-sided Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001.
0.9674–1.019, p < 0.0001). Besides miR-130a, miR-1234(AUC
0.9048, 95% CI 0.7881–1.021, p = 0.00047) and miR-451a (AUC
0.9221, 95% CI 0.7852–1.059, p = 0.00038) had an AUC >
0.90. The AUC of remaining eight miRNAs was 0.8929 for miR-
1290 (95% CI 0.7736–1.012, p = 0.00069), 0.8896 for miR-363
(95% CI 0.7514–1.028, p = 0.0010), 0.8799 for miR-20a (95%
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FIGURE 4 | AUC analysis of receiver-operating characteristics. The area under the curve (AUC) (values given on the graphs) for miRNAs with significantly
decreased circulating levels was calculated for physiological changes induced by 45 days of bed rest.
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CI 0.7171–1.043, p = 0.0014), 0.8701 for miR-151-5p (95%
CI 0.7223–1.018, p = 0.0018), 0.8571 for miR-151-3p (95% CI
0.6948–1.019, p = 0.0026), 0.8036 for miR-103 (95% CI 0.6089–
0.9983, p = 0.0087), 0.7532 for miR-199a-3p (95% CI 0.5381–
0.9684, p = 0.033), and 0.6788 for miR-148a (95% CI 0.4504–
0.9067, p = 0.12). The sensitivity and specificity associated
with the optimal cut-off points are shown in Table 2. miR-130a
showed the highest sensitivity of 92.6% and a specificity of 100%.
The results suggested that these 10 miRNAs might be biomarkers
of physiological changes induced by HDT bed rest.
Correlation of Circulating miRNA Level
with Bone Loss Induced by HDT Bed Rest
It is well known that bone loss during long-term space flight is a
critical issue that poses significant risk to the health of astronauts.
Bed rest has proved its usefulness as a reliable simulation model
for bone loss during space flight (Wang et al., 2012). After
we had determined the differential miRNA levels pattern, we
examined whether any miRNA was correlated with the clinical
prognostic variables of bone loss induced by HDT bed rest. In
TABLE 2 | Sensitivity and specificity of the regulated miRNAs in the serum
of individuals after 45 days of HDT bed rest.
miRNAs Sensitivity (%) Specificity (%)
miR-130a 92.9 100
miR-451a 92.9 90.9
miR-1234 92.9 75
miR-1290 64.3 100
miR-363 92.9 81.8
miR-20a 92.9 81.8
miR-151-5p 92.9 72.7
miR-151-3p 92.9 81.8
miR-103 85.7 75
miR-199a-3p 92.9 63.6
Data were evaluated via a cut-off point.
this bed rest experiment, all 16 subjects completed the 45 days
bed rest. BMD at hip and lumbar spine (L2–L4) were lower
after 45 days bed rest as compared with baseline. And after 10
days recovery, BMD at lumbar spine (L2–L4) were significantly
increased as compared with BR-45d (Supplementary Figure 1).
Bed rest had a significant effect on biochemistry markers—bone
alkaline phosphatase (BALP), osteocalcin (OCN), procollagen
type I carboxy-terminal propeptide (PICP) and beta-carboxy-
terminal cross-linking telopeptide of type I collagen (β-CTX)
(Supplementary Table 1).We use Pearson’s correlation to analysis
coefficients of significantly changed circulating miRNAs and
bone parameters mentioned above. As shown in Table 3, the
level of miR-1234 was significantly associated with hip BMD of
subjects at total time points (r = 0.2853, p < 0.05) and 45 days
of bed rest (r = 0.4581, p < 0.05), respectively. Table 4 showed
the significant negative correlation between miR-20a and lumbar
spine BMD at 45 days of bed rest (r = –0.5456, p < 0.05).
However, no correlation with BMD was found for other eight
miRNAs.
In addition, significant correlations were found for miR-1290
(r = −0.2706, p < 0.05), miR-130a (r = −0.2984, p < 0.05),
and miR-1234 (r = −0.3545, p < 0.05) with total serum BALP
of individuals at total time points respectively. Meantime, miR-
130a (r = −0.5439, p < 0.05) and miR-1234 (r = −0.7367,
p < 0.01) were significantly associated with serum BALP at 45
day of bed rest (Table 5). As shown in Table 6, miR-1234 had
significantly positive correlation with serum OCN at 45 days of
bed rest (r = 0.7288, p < 0.01). Table 7 showed serum PICP
at total time points were significantly associated with miR-363
(r = −0.3347 p < 0.05), miR-1290 (r = −0.2908, p < 0.05),
miR-103 (r = −0.2739, p < 0.05), miR-451a (r = −0.3204,
p < 0.05), miR-130a (r = −0.3402, p < 0.05), miR-1234 (r
= −0.2396, p < 0.05), and miR-20a (r = −0.3148, p < 0.05),
respectively. At 45 days of bed rest, miR-451a (r = −0.5007, p <
0.05) andmiR-1234 (r= 0.7418, p< 0.01) had significant positive
correlations with serum PICP, and only miR-130a (r = −0.5859,
p < 0.05) were significantly associated with serum PICP at 10
TABLE 3 | Pearson correlation coefficients of significantly decreased miRNAs and BMD at hip.
Total Baseline BR-45d R-10d
Circulating miRNA Corr with BMD p Corr with BMD p Corr with BMD p Corr with BMD p
miR-363 0.1008 0.5414 0.08712 0.7990 0.1745 0.5508 −0.08284 0.7783
miR-1290 −0.06863 0.6739 −0.3305 0.2941 −0.06903 0.8146 0.08109 0.7829
miR-103 0.1540 0.3427 0.06245 0.8471 0.03955 0.8932 0.3399 0.2344
miR-451a 0.2362 0.0739 0.1769 0.6029 0.04399 0.8813 0.3108 0.2795
miR-130a −0.1561 0.3361 −0.4888 0.1068 −0.3902 0.1678 −0.1207 0.6810
miR-1234 0.2853 <0.05 0.2804 0.3773 0.4581 <0.05 0.1687 0.5816
miR-20a 0.1091 0.5086 0.02640 0.9386 0.1661 0.5705 −0.01745 0.9528
miR-199a-3p 0.1691 0.3035 0.1490 0.6619 0.1063 0.7176 0.2895 0.3153
miR-151-3p 0.1730 0.2991 0.1389 0.6837 0.3545 0.2136 0.03989 0.8970
miR-151-5p 0.1820 0.2675 0.1366 0.6888 0.3045 0.2899 0.1603 0.5841
Values are Pearson correlation coefficient (r) and relative computed p value. Significant values are highlighted in bold. Total, sum of baseline, BR-45d and R-10d; Baseline, pre-bed rest;
BR-45d, post-45 days of bed rest; R-10d, recovery for 10 days.
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TABLE 4 | Pearson correlation coefficients of significantly decreased miRNAs and BMD at Lumbar spine.
Total Baseline BR-45d R-10d
Circulaing miRNA Corr with BMD p Corr with BMD p Corr with BMD p Corr with BMD p
miR-363 −0.02957 0.8582 −0.03700 0.914 −0.4792 0.0830 −0.2003 0.4923
miR-1290 0.1550 0.3395 −0.1407 0.6627 0.3970 0.1599 −0.08242 0.7794
miR-103 −0.1342 0.4090 −0.4553 0.1369 −0.4420 0.1136 −0.03782 0.8979
miR-451a 0.1401 0.3949 0.05163 0.8802 −0.4132 0.1420 0.1450 0.6208
miR-130a 0.1187 0.4657 0.02214 0.9456 −0.4719 0.0885 −0.2118 0.4673
miR-1234 0.1305 0.4221 0.1886 0.4259 −0.2051 0.4819 −0.1577 0.5903
miR-20a −0.02151 0.8966 −0.3191 0.3388 −0.5456 <0.05 0.4088 0.1467
miR-199a-3p −0.1276 0.4390 −0.3479 0.2945 −0.4506 0.1059 0.09329 0.7511
miR-151-3p 0.03943 0.8142 −0.1416 0.6778 −0.1099 0.7083 −0.06473 0.8336
miR-151-5p −0.03541 0.8305 −0.3249 0.3297 −0.3059 0.2875 0.2138 0.4630
Values are Pearson correlation coefficient (r) and relative computed p value. Significant values are highlighted in bold.
TABLE 5 | Pearson correlation coefficients of significantly decreased miRNAs and Serum BALP.
Total Baseline BR-45d R-10d
Circulaing miRNA Corr with BALP p Corr with BALP p Corr with BALP p Corr with BALP p
miR-363 −0.2427 0.0683 −0.2617 0.4370 −0.3038 0.2910 0.01739 0.9530
miR-1290 −0.2706 <0.05 −0.4842 0.1107 0.2535 0.3818 −0.2405 0.4075
miR-103 −0.1632 0.3144 −0.04615 0.8868 −0.2208 0.4482 −0.2770 0.3378
miR-451a −0.2271 0.1644 −0.2162 0.5231 −0.3907 0.0836 0.08602 0.7700
miR-130a −0.2984 <0.05 −0.3791 0.2243 −0.5439 <0.05 −0.3022 0.2937
miR-1234 −0.3545 <0.05 −0.2663 0.4029 −0.7367 <0.01 −0.08088 0.7834
miR-20a −0.1033 0.5314 −0.07099 0.8357 −0.3149 0.2728 0.1044 0.7225
miR-199a-3p −0.01692 0.9186 0.01166 0.9728 −0.3357 0.2406 0.09405 0.7491
miR-151-3p 0.06645 0.6918 0.01067 0.9752 −0.07889 0.7886 −0.05065 0.8695
miR-151-5p −0.03009 0.8557 −0.002424 0.9944 −0.1267 0.6661 0.1696 0.5622
Values are Pearson correlation coefficient (r) and relative computed p-value. Significant values are highlighted in bold. BALP, Bone alkaline phosphatase.
days of recovery. Table 8 showed no significant correlation with
β-CTX which was a marker of bone resorption was found for all
miRNAs. These results indicated that miR-1234 had significant
correlations with most of bone parameters of individuals in this
bed rest experiment. Circulating miR-1234might be the potential
biomarker of bone loss induced by HDT bed rest or spaceflight.
DISCUSSION
In this study, we report for the first time the association of
certain serum circulating miRNAs with bone loss induced by 45
days of bed rest. We characterize the circulating miRNA profile
in individuals after bed rest and identify circulating miRNAs
which can best reflect the level of bone loss induced by bed rest.
Expression profiling of circulating miRNA revealed significant
downregulation of 37 miRNAs and upregulation of 2 miRNAs,
while only 11 of the downregulated miRNAs were further
validated in a larger volunteer cohort using qPCR.We found that
10 of these 11 miRNAs had an ROC curve that distinguished the
status after bed rest. Importantly, significant positive correlations
were identified between bone loss parameters and several
miRNAs, eventually miR-1234 showed clinical significance
in detecting the bone loss of individuals after 45 days of
bed rest.
To our knowledge, the function of miR-1234 in bone
remodeling remains unknown. Only a few studies showed
miR-1234 might play a role in regulation of tumorigenesis
of B-cell lymphoma (Hogfeldt et al., 2014) and used miR-
1234 as biomarker for predicting survival in patients with
nasopharyngeal carcinoma (Liu et al., 2014). Functional analysis
in targetScan 6.0 showed that miR-1234 could target different
genes involved in bone remodeling and in basic biological
processes such as cell-cell signaling, DNA replication, cell
death and survival. Some of differentially expressed circulating
miRNAs appear to be involved in the biologic processes of bone
remodeling. miR-103 inhibits osteoblast proliferation through
suppression of Cav1.2 expression under simulated microgravity
condition in vitro (Sun et al., 2015). And miR-20a can promote
osteogenic differentiation of human mesenchymal stem cells by
co-regulating BMP signaling (Zhang et al., 2011). miR-130a play
an important role in regulating the expression of TNF-α in
human chondrocytes (Li et al., 2015).
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TABLE 6 | Pearson correlation coefficients of significantly decreased miRNAs and Serum OCN.
Total Baseline BR-45d R-10d
Circulaing miRNA Corr with OCN p Corr with OCN p Corr with OCN p Corr with OCN p
miR-363 0.08861 0.5917 0.3045 0.3625 0.3550 0.2130 −0.02822 0.9237
miR-1290 0.1865 0.2491 0.2595 0.4155 0.05659 0.8476 0.4043 0.0758
miR-103 0.1241 0.4456 0.1696 0.2991 0.3863 0.1724 0.2024 0.4876
miR-451a 0.02562 0.8769 0.2699 0.4222 0.4168 0.1382 −0.1551 0.5966
miR-130a 0.07062 0.6650 0.2430 0.4467 0.1731 0.5541 0.1633 0.5769
miR-1234 0.1839 0.2560 0.3477 0.1330 0.7288 <0.01 0.1559 0.5945
miR-20a −0.05131 0.7564 0.1746 0.6077 0.3747 0.1868 0.1559 0.5945
miR-199a-3p −0.0003102 0.9985 0.1561 0.6467 0.3215 0.2623 0.03708 0.8998
miR-151-3p −0.07235 0.6660 0.08965 0.7932 0.08592 0.7710 0.2542 0.4021
miR-151-5p −0.01071 0.9484 0.1724 0.6121 0.1824 0.5557 −0.08378 0.7758
Values are Pearson correlation coefficient (r) and relative computed p value. Significant values are highlighted in bold. OCN, osteocalcin.
TABLE 7 | Pearson correlation coefficients of significantly decreased miRNAs and Serum PICP.
Total Baseline BR-45d R-10d
Circulaing miRNA Corr with PICP p Corr with PICP p Corr with PICP p Corr with PICP p
miR-363 0.3347 <0.05 0.3471 0.2956 0.4141 0.0705 0.2323 0.2121
miR-1290 0.2908 <0.05 0.3110 0.1626 0.1007 0.366 −0.1253 0.6695
miR-103 0.2739 <0.05 0.2005 0.5322 0.4337 0.0606 0.08559 0.7711
miR-451a 0.3204 <0.05 0.3073 0.3580 0.5007 <0.05 0.1034 0.7250
miR-130a 0.3402 <0.05 0.2640 0.4069 0.2323 0.4242 0.5859 <0.05
miR-1234 0.2396 <0.05 0.06216 0.8478 0.7418 <0.01 0.1092 0.7103
miR-20a 0.3148 <0.05 0.2013 0.5528 0.4376 0.0588 0.1243 0.6721
miR-199a-3p 0.2081 0.2036 0.1720 0.6130 0.3248 0.2572 −0.2362 0.4163
miR-151-3p 0.1751 0.2929 0.1271 0.7095 0.1059 0.7186 −0.4227 0.0751
miR-151-5p 0.2029 0.2154 0.1878 0.5804 0.1456 0.6195 −0.2113 0.4684
Values are Pearson correlation coefficient (r) and relative computed p value. Significant values are highlighted in bold. PICP, procollagen type I carboxy-terminal propeptide.
TABLE 8 | Pearson correlation coefficients of significantly decreased miRNAs and Serum β-CTX.
Total Baseline BR-45d R-10d
Circulaing miRNA Corr with β-CTX p Corr with β-CTX p Corr with β-CTX p Corr with β-CTX p
miR-363 −0.05057 0.7598 0.03450 0.9198 0.3273 0.1267 −0.08325 0.7772
miR-1290 −0.1554 0.3384 −0.3130 0.3219 −0.2736 0.3439 0.06888 0.8150
miR-103 −0.08435 0.6048 −0.07971 0.8055 0.06375 0.8286 −0.2439 0.4007
miR-451a −0.1384 0.4008 −0.001824 0.9958 0.4477 0.1084 −0.3440 0.2285
miR-130a −0.09952 0.5467 −0.2118 0.5087 0.2636 0.3624 −0.2589 0.3931
miR-1234 −0.1319 0.4172 −0.2859 0.3677 0.2087 0.2370 0.1067 0.7167
miR-20a −0.06211 0.7072 0.2802 0.4039 0.2947 0.1532 −0.4969 0.0706
miR-199a-3p 0.08236 0.6182 0.3519 0.2886 0.3928 0.1648 −0.2017 0.4892
miR-151-3p 0.05143 0.7591 0.2571 0.4454 0.3620 0.2034 −0.01387 0.9641
miR-151-5p 0.003863 0.9814 0.3416 0.3039 0.1764 0.5463 −0.2807 0.3311
Values are Pearson correlation coefficient (r) and relative computed p value. β-CTX, beta-carboxy-terminal cross-linking telopeptide of type I collagen.
miR-451a, miR-363, miR-1290, miR-363, miR-151-5p, and
miR-151-3p had an optimal area value under the curve >0.85,
indicating that these circulating miRNAs levels might be useful
biological markers for assessing the risk of bed rest or simulated
microgravity. However, no correlation with BMD after 45
days of bed rest was found for these miRNAs. Bed rest has
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proved its usefulness as a reliable simulation model for most
physiological effects of spaceflight, for example muscle wasting,
cardiovascular deconditioning, adverse metabolic changes, and
bone demineralization (Jost, 2008). Except bone loss, these
miRNAs levels may have correlation with other physiological
effect of bed rest-muscle wasting, cardiovascular deconditioning,
or adverse metabolic changes.
miRNAs have been demonstrated to play crucial roles in
many physiological and pathophysiological processes (Ling et al.,
2013a,b,c; Wang et al., 2013; Zhao et al., 2015). To date, only a
very few studies have demonstrated that specificmiRNA involved
in bone loss induced by spaceflight or simulated microgravity
(Wang et al., 2013). Our previous study indicated that miR-214
directly targeted ATF4 to inhibit osteoblast activity and bone
formation. And we found simulated microgravity (hindlimb
unloading model)—induced deleterious changes in trabecular
bone mass and trabecular architecture were efficiently attenuated
by the inhibition of miR-214 in mice (Wang et al., 2013).
Unfortunately, the microRNA microarray results showed no
significant change in miR-214 level in this study, however
qPCR results demonstrated circulating miR-214 levels were
significantly increased in plasma of individuals after bed rest
(unpublished data). Therefore, the significantly changed miRNA
in plasma of individuals after bed rest may be involved in the
bone loss induced by spaceflight or disuse.
To date, there have been several biochemical markers of
bone turnover, for instance, BALP, OCN, PICP, and so on (Lee
and Vasikaran, 2012; Wheater et al., 2013; Al Nofal et al.,
2015). However, these biomarkers have different disadvantages.
The serum BALP levels have up to 20% cross reactivity with
liver isoforms (Seibel, 2005), OCN levels are unstable in serum
and have short half-life of a few minutes (Lee and Vasikaran,
2012), and PICP also have short half-life and are sensitive
to thyroid hormones and IGF-1(Szulc and Delmas, 2008).
miRNAs are circulating freely in the mammalian blood and
can be predicted as biomarker for early diagnosis of disease
(Guay and Regazzi, 2013). Circulating miRNAs are stable under
different storage conditions and can be measured using assays
that are specific, sensitive, and reproducible (Seeliger et al.,
2014). So far, expression profiling of circulating miRNAs as
biomarkers revealed both diagnostic and prognostic potential
in cardiovascular disease (McManus and Ambros, 2011) and
more than 10 types of cancer (Mo et al., 2012). Also, circulating
miRNAs can be used as biomarkers for diagnostic purpose in
osteoporotic patients (Seeliger et al., 2014). However, signatures
of circulating miRNAs have not been characterized in individuals
with bone loss induced by disuse or bed rest. To our knowledge,
this is the first study to evaluate the circulating miRNA
fingerprint in bed rest people and analyze the correlation between
circulating miRNA levels and bone loss induced by bed rest.
In conclusion, the present study provides the evidence of an
altered circulating miRNA expression profile in HDT bed-rest
people. Ten circulatingmiRNAs (miR-103, 130a, 1234, 1290, 151-
5p, 151-3p, 199a-3p, 20a, 363, and 451a) have potential detective
value for distinguishing the physiological changes after bed-rest,
and miR-1234 might be the diagnostic biomarker of bone loss
induced by bed rest or disuse.
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